A novel gas–liquid segmented microfluidic platform has been developed, allowing for the direct access to ¹¹ C-labelled drug-like molecules.
No takes yet. Share an insight, caveat, or question.
Dahl et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: